Custom immune cells take on advanced colorectal cancer in early trial
Disease control
Recruiting now
This early-stage trial is testing a personalized treatment called iNeo-Vac-T01 for people with advanced colorectal cancer. The therapy uses a patient's own immune cells, which are trained in a lab to recognize and attack unique markers on their tumor. The study will enroll 20 par…
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC